UPC APP 60996/2024

—·EP4026488: TRANSCUTANEOUS ANALYTE SENSOR SYSTEMS AND METHODS

Case details: Status
—
Action
Procedural application
Category
Other Procedural
Parties: Claimants
DexCom, Inc.
Reps: Markus Grosch (Quinn Emanuel Urquhart & Sullivan LLP)
Respondents
Abbott Laboratories
Abbott Diabetes Care Inc.
Abbott GmbH
Abbott Diagnostics GmbH
Abbott Laboratories GmbH
Abbott Logistics B.V.
Abbott France (S.A.S.)
Abbott s.r.l.
Abbott Gesellschaft m.b.H.
Abbott B.V.
Abbott (S.A./N.V.)
Abbott Scandinavia Aktiebolag
Abbott Oy
Reps: Dietrich Kamlah (Taylor Wessing); Christian Lederer (Taylor Wessing); Gisbert Hohagen (Taylor Wessing)
Division: Dusseldorf LD
Judges: —
Technology: Pharmaceutical & Medical
Language: —
First decided: Nov 20, 2024

Decisions

2024-11-20
Generic application
Düsseldorf Local Division procedural order extending the time limit for DexCom Inc. to file its Rejoinder to the Counterclaim for Revocation and Reply to Application to Amend until 11 December 2024, in DexCom v. Abbott entities (EP 4 026 488). The extension was granted on grounds of fairness/equity because the previous time period for defendants had been similarly extended with claimant's consent.
Legal issues:Extension of time limits (R. 9.3(a) RoP)Fairness in setting equal procedural deadlines

Documents